{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T06:56:08Z","timestamp":1777877768744,"version":"3.51.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["HV22C1234."],"award-info":[{"award-number":["HV22C1234."]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Vaccines"],"DOI":"10.1038\/s41541-026-01385-0","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T07:45:25Z","timestamp":1772005525000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development of a Prophylactic mRNA Vaccine for Severe Fever with Thrombocytopenia Syndrome Using HSA based LNP"],"prefix":"10.1038","volume":"11","author":[{"given":"Tsenddari","family":"Ganbold","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enkhchimeg","family":"Lkhagva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enkhtsatsral","family":"Munkhtur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satabdi","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeon Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seong-Tschool","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"key":"1385_CR1","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1056\/NEJMoa1010095","volume":"364","author":"XJ Yu","year":"2011","unstructured":"Yu, X. J. et al. Fever with thrombocytopenia associated with a novel bunyavirus in China. N. Engl. J. Med 364, 1523\u20131532 (2011).","journal-title":"N. Engl. J. Med"},{"key":"1385_CR2","doi-asserted-by":"publisher","first-page":"O870","DOI":"10.1111\/1469-0691.12636","volume":"20","author":"YP Ding","year":"2014","unstructured":"Ding, Y. P. et al. Prognostic value of clinical and immunological markers in acute phase of SFTS virus infection. Clin. Microbiol. Infect. 20, O870\u2013O878 (2014).","journal-title":"Clin. Microbiol. Infect."},{"key":"1385_CR3","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s12276-021-00610-1","volume":"53","author":"MA Casel","year":"2021","unstructured":"Casel, M. A., Park, S. J. & Choi, Y. K. Severe fever with thrombocytopenia syndrome virus: emerging novel phlebovirus and their control strategy. Exp. Mol. Med. 53, 713\u2013722 (2021).","journal-title":"Exp. Mol. Med."},{"key":"1385_CR4","doi-asserted-by":"publisher","DOI":"10.1111\/ped.14853","volume":"64","author":"K Tran Quang","year":"2022","unstructured":"Tran Quang, K. et al. Study on the co-infection of children with severe community-acquired pneumonia. Pediatr. Int. 64, e14853. https:\/\/doi.org\/10.1111\/ped.14853 (2022).","journal-title":"Pediatr. Int."},{"key":"1385_CR5","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.3201\/eid2812.221183","volume":"28","author":"P Rattanakomol","year":"2022","unstructured":"Rattanakomol, P. et al. Severe fever with thrombocytopenia syndrome virus infection, Thailand, 2019-2020. Emerg. Infect. Dis. 28, 2572\u20132574 (2022).","journal-title":"Emerg. Infect. Dis."},{"key":"1385_CR6","doi-asserted-by":"publisher","first-page":"956","DOI":"10.4269\/ajtmh.24-0616","volume":"112","author":"S Charoensakulchai","year":"2025","unstructured":"Charoensakulchai, S., Matsuno, K., Nakayama, E. E., Shioda, T. & Imad, H. A. Epidemiological characteristics of severe fever with thrombocytopenia syndrome. Am. J. Trop. Med. Hyg. 112, 956\u2013962 (2025).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"1385_CR7","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3201\/eid2802.211532","volume":"28","author":"X Zhang","year":"2022","unstructured":"Zhang, X. et al. Rapid spread of severe fever with thrombocytopenia syndrome virus by parthenogenetic Asian longhorned ticks. Emerg. Infect. Dis. 28, 363\u2013372 (2022).","journal-title":"Emerg. Infect. Dis."},{"key":"1385_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ttbdis.2022.102115","volume":"14","author":"C Kaneko","year":"2023","unstructured":"Kaneko, C. et al. Seroprevalence of severe fever with thrombocytopenia syndrome virus in medium-sized wild mammals in Miyazaki, Japan. Ticks Tick. Borne Dis. 14, 102115. https:\/\/doi.org\/10.1016\/j.ttbdis.2022.102115 (2023).","journal-title":"Ticks Tick. Borne Dis."},{"key":"1385_CR9","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.ttbdis.2017.04.008","volume":"8","author":"SH Lee","year":"2017","unstructured":"Lee, S. H. et al. Molecular detection and phylogenetic analysis of severe fever with thrombocytopenia syndrome virus in shelter dogs and cats in the Republic of Korea. Ticks Tick. Borne Dis. 8, 626\u2013630 (2017).","journal-title":"Ticks Tick. Borne Dis."},{"key":"1385_CR10","unstructured":"WHO. Annual Review of Diseases Prioritized under the Research and Development Blueprint, Informal Consultation (WHO, Geneva, Switzerland, 2018)."},{"key":"1385_CR11","unstructured":"National Institute of Allergy and Infectious Diseases (NIAID) Emerging Infectious Diseases\/Pathogens. National Institute of Allergy and Infectious Diseases [(accessed on 19 November 2023)] (2018)."},{"key":"1385_CR12","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrd.2017.243","volume":"17","author":"N Pardi","year":"2018","unstructured":"Pardi, N., Hogan, M. J., Porter, F. W. & Weissman, D. mRNA vaccines - a new era in vaccinology. Nat. Rev. Drug Discov. 17, 261\u2013279 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1385_CR13","doi-asserted-by":"publisher","unstructured":"Kim, D., Lai, C. J., Cha, I. & Jung, J. U. Current Progress of Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV) Vaccine Development. Viruses https:\/\/doi.org\/10.3390\/v16010128 (2024).","DOI":"10.3390\/v16010128"},{"key":"1385_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.bsheal.2021.12.008","volume":"4","author":"AQ Li","year":"2022","unstructured":"Li, A. Q. et al. Immunogenicity and protective efficacy of an inactivated SFTS vaccine candidate in mice. Biosaf. Health 4, 45\u201352 (2022).","journal-title":"Biosaf. Health"},{"key":"1385_CR15","doi-asserted-by":"publisher","unstructured":"Yoshikawa, T. Vaccine development for severe fever with thrombocytopenia syndrome. Viruses https:\/\/doi.org\/10.3390\/v13040627 (2021).","DOI":"10.3390\/v13040627"},{"key":"1385_CR16","volume":"12","author":"QR Huang","year":"2021","unstructured":"Huang, Q. R. et al. A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2. Nat. Commun. 12, 2021 (2021).","journal-title":"Nat. Commun."},{"key":"1385_CR17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1292\/jvms.23-0375","volume":"86","author":"T Shimoyama","year":"2024","unstructured":"Shimoyama, T. et al. Potent immunogenicity and neutralization of recombinant adeno-associated virus expressing the glycoprotein of severe fever with thrombocytopenia virus. J. Vet. Med. Sci. 86, 228\u2013238 (2024).","journal-title":"J. Vet. Med. Sci."},{"key":"1385_CR18","doi-asserted-by":"publisher","unstructured":"Zhang, L. et al. Characterization of severe fever with thrombocytopenia syndrome in rural regions of Zhejiang, China. PLoS ONE 9, e111127 https:\/\/doi.org\/10.1371\/journal.pone.0111127 (2014).","DOI":"10.1371\/journal.pone.0111127"},{"key":"1385_CR19","doi-asserted-by":"publisher","unstructured":"Xia, T. et al. Glucosylceramide is essential for Heartland and Dabie bandavirus glycoprotein-induced membrane fusion. PLoS Pathog. 19, e1011232 https:\/\/doi.org\/10.1371\/journal.ppat.1011232 (2023).","DOI":"10.1371\/journal.ppat.1011232"},{"key":"1385_CR20","doi-asserted-by":"publisher","unstructured":"Halldorsson, S. et al. Shielding and activation of a viral membrane fusion protein. Nat. Commun. 9, 349 https:\/\/doi.org\/10.1038\/s41467-017-02789-2 (2018).","DOI":"10.1038\/s41467-017-02789-2"},{"key":"1385_CR21","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.3390\/v6041801","volume":"6","author":"N Cifuentes-Mu\u00f1oz","year":"2014","unstructured":"Cifuentes-Mu\u00f1oz, N., Salazar-Quiroz, N. & Tischler, N. D. Hantavirus Gn and Gc envelope glycoproteins: key structural units for virus cell entry and virus assembly. Viruses 6, 1801\u20131822 (2014).","journal-title":"Viruses"},{"key":"1385_CR22","doi-asserted-by":"publisher","unstructured":"Kim, D. et al. Self-assembling Gn head ferritin nanoparticle vaccine provides full protection from lethal challenge of in aged ferrets. mBio 14, e0186823 https:\/\/doi.org\/10.1128\/mbio.01868-23 (2023).","DOI":"10.1128\/mbio.01868-23"},{"key":"1385_CR23","doi-asserted-by":"publisher","unstructured":"Kim, D. et al. SFTSV Gn-Head mRNA vaccine confers efficient protection against lethal viral challenge. J. Med. Virol. 95, e29203 https:\/\/doi.org\/10.1002\/jmv.29203 (2023).","DOI":"10.1002\/jmv.29203"},{"key":"1385_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-023-00771-2","volume":"8","author":"JY Kim","year":"2023","unstructured":"Kim, J. Y. et al. mRNA vaccine encoding Gn provides protection against severe fever with thrombocytopenia syndrome virus in mice. NPJ Vaccines 8, 167 (2023).","journal-title":"NPJ Vaccines"},{"key":"1385_CR25","doi-asserted-by":"publisher","first-page":"e1007375","DOI":"10.1371\/journal.ppat.1007375","volume":"15","author":"KH Kim","year":"2019","unstructured":"Kim, K. H. et al. An anti-Gn glycoprotein antibody from a convalescent patient potently inhibits the infection of severe fever with thrombocytopenia syndrome virus. PLoS Pathog. 15, e1007375 (2019).","journal-title":"PLoS Pathog."},{"key":"1385_CR26","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S1473-3099(14)70718-2","volume":"14","author":"Q Liu","year":"2014","unstructured":"Liu, Q., He, B., Huang, S. Y., Wei, F. & Zhu, X. Q. Severe fever with thrombocytopenia syndrome, an emerging tick-borne zoonosis. Lancet Infect. Dis. 14, 763\u2013772 (2014).","journal-title":"Lancet Infect. Dis."},{"key":"1385_CR27","doi-asserted-by":"publisher","unstructured":"Albertsen, C. H. et al. The role of lipid components in lipid nanoparticles for vaccines and gene therapy. Adv. Drug Del. Rev. 188, 114416 https:\/\/doi.org\/10.1016\/j.addr.2022.114416 (2022).","DOI":"10.1016\/j.addr.2022.114416"},{"key":"1385_CR28","doi-asserted-by":"publisher","first-page":"319","DOI":"10.4155\/tde-2016-0006","volume":"7","author":"AM Reichmuth","year":"2016","unstructured":"Reichmuth, A. M., Oberli, M. A., Jaklenec, A., Langer, R. & Blankschtein, D. mRNA vaccine delivery using lipid nanoparticles. Ther. Deliv. 7, 319\u2013334 (2016).","journal-title":"Ther. Deliv."},{"key":"1385_CR29","doi-asserted-by":"publisher","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","volume":"15","author":"R Tenchov","year":"2021","unstructured":"Tenchov, R., Bird, R., Curtze, A. E. & Zhou, Q. Q. Lipid nanoparticles-from liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement. ACS Nano 15, 16982\u201317015 (2021).","journal-title":"ACS Nano"},{"key":"1385_CR30","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.jaip.2020.09.029","volume":"9","author":"P Sellaturay","year":"2021","unstructured":"Sellaturay, P., Nasser, S. & Ewan, P. Polyethylene glycol-induced systemic allergic reactions (anaphylaxis). J. Allergy Clin. Immunol. Pract. 9, 670\u2013675 (2021).","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"1385_CR31","doi-asserted-by":"publisher","unstructured":"Li, C. Y., Zhang, D. G., Pan, Y. J. & Chen, B. Q. Human serum albumin based nanodrug delivery systems: recent advances and future perspective. Polymers 15, 3354 https:\/\/doi.org\/10.3390\/polym15163354 (2023).","DOI":"10.3390\/polym15163354"},{"key":"1385_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2019.102089","volume":"23","author":"HJ Chung","year":"2020","unstructured":"Chung, H. J., Kim, H. J. & Hong, S. T. Tumor-specific delivery of a paclitaxel-loading HSA-haemin nanoparticle for cancer treatment. Nanomedicine 23, 102089. https:\/\/doi.org\/10.1016\/j.nano.2019.102089 (2020).","journal-title":"Nanomedicine"},{"key":"1385_CR33","doi-asserted-by":"publisher","unstructured":"Zhai, C. K. et al. Oral delivery of a host-directed antiviral, niclosamide, as a cholate-coated nanoformulation. Int. J. Antimicrob. Agents 62, 106973 https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106973 (2023).","DOI":"10.1016\/j.ijantimicag.2023.106973"},{"key":"1385_CR34","doi-asserted-by":"publisher","unstructured":"Zhai, C. et al. Noncovalent nanoformulation of a drug candidate with limited systemic delivery for systemic oral delivery as much as a typical common oral drug. SSRN Electron. J. https:\/\/doi.org\/10.2139\/ssrn.4189035 (2022).","DOI":"10.2139\/ssrn.4189035"},{"key":"1385_CR35","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1128\/CVI.00222-13","volume":"20","author":"X Guo","year":"2013","unstructured":"Guo, X. et al. Human antibody neutralizes severe fever with thrombocytopenia syndrome virus, an emerging hemorrhagic fever virus. Clin. Vaccine Immunol. 20, 1426\u20131432 (2013).","journal-title":"Clin. Vaccine Immunol."},{"key":"1385_CR36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.pep.2017.01.003","volume":"132","author":"C Attallah","year":"2017","unstructured":"Attallah, C., Etcheverrigaray, M., Kratje, R. & Oggero, M. A highly efficient modified human serum albumin signal peptide to secrete proteins in cells derived from different mammalian species. Protein Expr. Purif. 132, 27\u201333 (2017).","journal-title":"Protein Expr. Purif."},{"key":"1385_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02488-3","volume":"22","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. Efficient signal sequence of mRNA vaccines enhances the antigen expression to expand the immune protection against viral infection. J. Nanobiotechnol. 22, 295 (2024).","journal-title":"J. Nanobiotechnol."},{"key":"1385_CR38","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.4161\/rna.22269","volume":"9","author":"T Schlake","year":"2012","unstructured":"Schlake, T., Thess, A., Fotin-Mleczek, M. & Kallen, K. J. Developing mRNA-vaccine technologies. RNA Biol. 9, 1319\u20131330 (2012).","journal-title":"RNA Biol."},{"key":"1385_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s13273-021-00171-4","volume":"18","author":"SC Kim","year":"2022","unstructured":"Kim, S. C. et al. Modifications of mRNA vaccine structural elements for improving mRNA stability and translation efficiency. Mol. Cell Toxicol. 18, 1\u20138 (2022).","journal-title":"Mol. Cell Toxicol."},{"key":"1385_CR40","doi-asserted-by":"publisher","unstructured":"Kirshina, A. et al. Effects of combinations of untranslated-region sequences on translation of mRNA. Biomolecules https:\/\/doi.org\/10.3390\/biom13111677 (2023).","DOI":"10.3390\/biom13111677"},{"key":"1385_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.797189","volume":"12","author":"J Sun","year":"2021","unstructured":"Sun, J. et al. Animal model of severe fever with thrombocytopenia syndrome virus infection. Front. Microbiol. 12, 797189. https:\/\/doi.org\/10.3389\/fmicb.2021.797189 (2021).","journal-title":"Front. Microbiol."},{"key":"1385_CR42","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s42826-020-00070-0","volume":"36","author":"SC Park","year":"2020","unstructured":"Park, S. C. et al. Pathogenicity of severe fever with thrombocytopenia syndrome virus in mice regulated in type I interferon signaling: Severe fever with thrombocytopenia and type I interferon. Lab Anim. Res. 36, 38 (2020).","journal-title":"Lab Anim. Res."},{"key":"1385_CR43","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1097\/MOG.0000000000001012","volume":"40","author":"H Shroff","year":"2024","unstructured":"Shroff, H. COVID-19 vaccine-induced liver injury. Curr. Opin. Gastroenterol. 40, 119\u2013125 (2024).","journal-title":"Curr. Opin. Gastroenterol."},{"key":"1385_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-020-00257-5","volume":"5","author":"NE Bopp","year":"2020","unstructured":"Bopp, N. E. et al. Baseline mapping of severe fever with thrombocytopenia syndrome virology, epidemiology and vaccine research and development. NPJ Vaccines 5, 111 (2020).","journal-title":"NPJ Vaccines"},{"key":"1385_CR45","doi-asserted-by":"publisher","first-page":"825","DOI":"10.14218\/JCTH.2021.00345","volume":"10","author":"S Lu","year":"2022","unstructured":"Lu, S. et al. Liver function derangement in patients with severe fever and thrombocytopenia syndrome. J. Clin. Transl. Hepatol. 10, 825\u2013834 (2022).","journal-title":"J. Clin. Transl. Hepatol."},{"key":"1385_CR46","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00281-017-0640-2","volume":"39","author":"JR Teijaro","year":"2017","unstructured":"Teijaro, J. R. Cytokine storms in infectious diseases. Semin Immunopathol. 39, 501\u2013503 (2017).","journal-title":"Semin Immunopathol."},{"key":"1385_CR47","doi-asserted-by":"publisher","unstructured":"Gu, Y. et al. The mechanism behind influenza virus cytokine storm. Viruses https:\/\/doi.org\/10.3390\/v13071362 (2021).","DOI":"10.3390\/v13071362"},{"key":"1385_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2020.100707","volume":"45","author":"JT England","year":"2021","unstructured":"England, J. T. et al. Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes. Blood Rev. 45, 100707. https:\/\/doi.org\/10.1016\/j.blre.2020.100707 (2021).","journal-title":"Blood Rev."},{"key":"1385_CR49","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1093\/infdis\/jis452","volume":"206","author":"Y Sun","year":"2012","unstructured":"Sun, Y. et al. Host cytokine storm is associated with disease severity of severe fever with thrombocytopenia syndrome. J. Infect. Dis. 206, 1085\u20131094 (2012).","journal-title":"J. Infect. Dis."},{"key":"1385_CR50","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jcv.2018.01.017","volume":"101","author":"JS Kwon","year":"2018","unstructured":"Kwon, J. S. et al. Kinetics of viral load and cytokines in severe fever with thrombocytopenia syndrome. J. Clin. Virol. 101, 57\u201362 (2018).","journal-title":"J. Clin. Virol."},{"key":"1385_CR51","doi-asserted-by":"publisher","first-page":"24842","DOI":"10.1021\/acsnano.4c05088","volume":"18","author":"T Korzun","year":"2024","unstructured":"Korzun, T. et al. Lipid nanoparticles elicit reactogenicity and sickness behavior in mice via toll-like receptor 4 and myeloid differentiation protein 88 axis. ACS Nano 18, 24842\u201324859 (2024).","journal-title":"ACS Nano"},{"key":"1385_CR52","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3389\/fmicb.2017.00104","volume":"8","author":"K Matsuno","year":"2017","unstructured":"Matsuno, K. et al. Animal models of emerging tick-borne phleboviruses: determining target cells in a lethal model of SFTSV infection. Front. Microbiol. 8, 104 (2017).","journal-title":"Front. Microbiol."},{"key":"1385_CR53","doi-asserted-by":"publisher","first-page":"5292","DOI":"10.1128\/JVI.00110-16","volume":"90","author":"H Tani","year":"2016","unstructured":"Tani, H. et al. Characterization of glycoprotein-mediated entry of severe fever with thrombocytopenia syndrome virus. J. Virol. 90, 5292\u20135301 (2016).","journal-title":"J. Virol."},{"key":"1385_CR54","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1128\/JVI.02277-13","volume":"88","author":"Y Liu","year":"2014","unstructured":"Liu, Y. et al. The pathogenesis of severe fever with thrombocytopenia syndrome virus infection in alpha\/beta interferon knockout mice: insights into the pathologic mechanisms of a new viral hemorrhagic fever. J. Virol. 88, 1781\u20131786 (2014).","journal-title":"J. Virol."},{"key":"1385_CR55","doi-asserted-by":"publisher","unstructured":"Mar\u00edn-Lopez, A. et al. Modeling arboviral infection in mice lacking the interferon alpha\/beta receptor. Viruses 11, 35 https:\/\/doi.org\/10.3390\/v11010035 (2019).","DOI":"10.3390\/v11010035"},{"key":"1385_CR56","doi-asserted-by":"publisher","first-page":"10053","DOI":"10.1073\/pnas.1120246109","volume":"109","author":"C Jin","year":"2012","unstructured":"Jin, C. et al. Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57\/BL6 mouse model. Proc. Natl. Acad. Sci. USA 109, 10053\u201310058 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1385_CR57","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12985-016-0677-1","volume":"14","author":"MM Liu","year":"2017","unstructured":"Liu, M. M., Lei, X. Y., Yu, H., Zhang, J. Z. & Yu, X. J. Correlation of cytokine level with the severity of severe fever with thrombocytopenia syndrome. Virol. J. 14, 6 (2017).","journal-title":"Virol. J."},{"key":"1385_CR58","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1093\/infdis\/jit603","volume":"209","author":"T Takahashi","year":"2014","unstructured":"Takahashi, T. et al. The first identification and retrospective study of severe fever with thrombocytopenia syndrome in Japan. J. Infect. Dis. 209, 816\u2013827 (2014).","journal-title":"J. Infect. Dis."},{"key":"1385_CR59","doi-asserted-by":"publisher","first-page":"4605","DOI":"10.1021\/ac500835k","volume":"86","author":"CK Hsu","year":"2014","unstructured":"Hsu, C. K. et al. Paper-based ELISA for the detection of autoimmune antibodies in body fluid-the case of bullous pemphigoid. Anal. Chem. 86, 4605\u20134610 (2014).","journal-title":"Anal. Chem."},{"key":"1385_CR60","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1080\/01926230600865523","volume":"34","author":"SA Elmore","year":"2006","unstructured":"Elmore, S. A. Enhanced histopathology of the spleen. Toxicol. Pathol. 34, 648\u2013655 (2006).","journal-title":"Toxicol. Pathol."}],"container-title":["npj Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01385-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01385-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01385-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:01:23Z","timestamp":1777590083000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41541-026-01385-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1385"],"URL":"https:\/\/doi.org\/10.1038\/s41541-026-01385-0","relation":{},"ISSN":["2059-0105"],"issn-type":[{"value":"2059-0105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"assertion":[{"value":"7 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"92"}}